Opinion of the Transparency Council – Treatment of patients with kidney disease
At its meeting on 12 May 2025, the Transparency Council adopted opinion No. 77/2025 on the assessment of the justification for introducing changes to the drug program B.113. “Treatment of patients with kidney disease (ICD-10 N.18)